Breaking News
0

Cognizant to buy TriZetto to boost healthcare business

TechnologySep 15, 2014 08:10AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
Cognizant to buy TriZetto to boost healthcare business

(Reuters) - Cognizant Technology Solutions Corp (O:CTSH) struck its biggest deal on Monday, acquiring healthcare IT services provider TriZetto Corp for $2.7 billion to beef up its slowing healthcare business.

Shares of the company, which is buying TriZetto from London-based private equity firm Apax Partners LLP, rose nearly 3 percent in premarket trading.

Cognizant's healthcare business, which accounted for about 26 percent of total revenue in 2013, has declined in the last three quarters.

The company provides services such as claims processing, billing and call center operations to insurers, hospitals and some state-run healthcare exchanges set up under President Barack Obama's Affordable Care Act, also known as Obamacare.

TriZetto provides information technology services, including care management and the administration of benefits. The company said it reaches 245,000 healthcare providers, representing more than half of the insured population in the United States.

Englewood, Colorado-based TriZetto is the latest U.S. healthcare IT services provider to be acquired as payers and providers of healthcare seek new ways to cut costs.

"Healthcare is undergoing structural shifts due to reform, cost pressure and shifting responsibilities between payers and providers," Cognizant CEO Francisco D'Souza said in a statement.

"This creates a significant growth opportunity, which TriZetto will help us capture."

The company in August forecast its slowest full-year sales growth in its 20-year history.

Cognizant, whose rivals include Tata Consultancy Services Ltd (NS:TCS) and Infosys Ltd (NS:INFY), said it expected revenue synergies of $1.5 billion over the next five years from the deal.

The company said the deal would immediately add to adjusted profit on closing, expected in the quarter ending December.

Apax Partners, which acquired TriZetto in 2008, was exploring a sale of the company, sources told Reuters in August.

TriZetto had 12-month earnings before interest, tax, depreciation and amortization of more than $190 million as of June 30, one of the sources had then said.

Cognizant said on Monday it would fund the deal through a combination of cash and debt and had secured $1 billion in financing.

The deal comes after private equity firms Silver Lake Partners LP and BC Partners Ltd sold health insurance claims processor MultiPlan Inc for $4.4 billion in March to a consortium led by Maurice "Hank" Greenberg's buyout firm Starr Investment Holdings LLC.

Credit Suisse, UBS Securities LLC and Centerview Partners advised Cognizant, while J.P.Morgan Securities LLC and Goldman Sachs & Co advised TriZetto.

Cognizant's shares closed at $44.76 on the Nasdaq on Friday.

(Reporting by Soham Chatterjee in Bangalore; Editing by Saumyadeb Chakrabarty and Sriraj Kalluvila)

Cognizant to buy TriZetto to boost healthcare business
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email